Your brain on day 24 isn't quite the same brain it was on day 14. This article goes into more detail than most cycle education on why. If you've already read why your worst mood week is always the same week, this is the deeper version of that science.
Most explanations of premenstrual mood symptoms stop at "progesterone drops, you feel low." That's accurate as far as it goes, but it leaves out the part that makes it interesting: progesterone itself isn't doing most of the work. It's what progesterone gets converted into.
Here's the longer version.
The two hormones doing the work
Progesterone
Progesterone is produced by the corpus luteum, the structure that forms from the empty follicle after ovulation. Its job in the cycle is to prepare the uterine lining for a potential pregnancy. Body temperature rises about half a degree Celsius after ovulation because of progesterone. Sleep architecture shifts. Metabolic rate increases slightly.
If pregnancy doesn't happen, the corpus luteum breaks down about 12 to 14 days after ovulation. Progesterone production stops. Levels fall from roughly 10 ng/mL at peak to under 1 ng/mL within a few days.1 That drop is what triggers menstruation.
But progesterone has effects in the brain that go beyond preparing the uterus, and those effects are mostly mediated by what progesterone becomes.
Estrogen
Estrogen (mostly estradiol, the main premenopausal form) peaks at ovulation, drops briefly, then has a smaller secondary peak in the mid-luteal phase. It supports serotonin and dopamine signalling, enhances BDNF (a growth factor for neurons), and has direct effects on cognition and mood.2
Estrogen also falls sharply alongside progesterone right before menstruation, removing another layer of mood-supporting chemistry at roughly the same time.
How progesterone becomes allopregnanolone
In your brain (and also in peripheral tissue), progesterone gets converted into other compounds through two enzymes:
- 5α-reductase converts progesterone to 5α-dihydroprogesterone (5α-DHP).
- 3α-hydroxysteroid dehydrogenase (3α-HSD) then converts 5α-DHP to allopregnanolone (also called 3α,5α-tetrahydroprogesterone, or 3α,5α-THP).3
The result is a different molecule, with different effects than progesterone itself. Allopregnanolone is a member of a class of compounds called neurosteroids.
This is important because progesterone barely crosses the blood-brain barrier well, but allopregnanolone is made directly in brain tissue (as well as in the ovaries, then transported). Its concentration in the brain follows progesterone levels in the body, but with the brain doing the conversion locally.
What allopregnanolone does in the brain
Allopregnanolone is a positive allosteric modulator at GABA-A receptors.4
GABA (gamma-aminobutyric acid) is the brain's main inhibitory neurotransmitter, meaning it dampens neural firing. When GABA acts on a GABA-A receptor, the neuron becomes less likely to fire. The result, at scale, is calm, reduced anxiety, easier sleep, less stress response.
A positive allosteric modulator is a compound that doesn't activate the receptor by itself, but makes the receptor more responsive when GABA does bind. Think of it as turning up the volume on GABA's calming signal.
The same mechanism is used by:
- Benzodiazepines (like Valium and Xanax), prescription anti-anxiety medications
- Barbiturates, older sedative medications
- Alcohol, at the doses people typically drink
- Other neurosteroids your body produces
This isn't an analogy. They all act on the same receptors, through similar mechanisms. Allopregnanolone is your body's natural version of the same chemistry.
At mid-luteal allopregnanolone levels (roughly 5 to 7 days after ovulation through 3 days before menstruation), this means calm, sleep support, anti-anxiety effect. Many women describe the mid-luteal as one of the most settled parts of the cycle.
The setup. For about 10 days each cycle, your brain has elevated levels of a compound that acts on the same receptors as benzodiazepines. Then, over about 3 to 4 days, that compound drops by 80 to 90%.
Why the drop hurts so much
If allopregnanolone is calming, why does the period right after a high allopregnanolone phase feel anxious and irritable, not just neutral?
The answer is GABA receptor adaptation.
When allopregnanolone is consistently elevated for several days, GABA-A receptors downregulate. The brain compensates for the constant calming signal by reducing receptor density or sensitivity. This is the same mechanism that makes long-term benzodiazepine use require larger doses for the same effect, and the same mechanism that drives benzodiazepine and alcohol withdrawal.
When allopregnanolone then drops sharply at the end of the luteal phase, the brain finds itself with:
- Far less of the calming compound
- Downregulated receptors that respond less to remaining GABA
- A few days of neurochemical recalibration ahead
The result, biochemically, looks similar to mild benzodiazepine withdrawal.5 Anxiety, irritability, sleep disruption, low frustration tolerance, sensitivity to stress. Then over a few days, as the brain re-adapts to lower allopregnanolone levels, the symptoms ease. That re-adaptation is roughly aligned with the start of menstruation and the first few days after.
The paradoxical response
For some women, the picture is different. About 3 to 8% of menstruating women experience PMDD (premenstrual dysphoric disorder), where late luteal symptoms are severe enough to significantly affect daily life.6
One explanation that has emerged from research over the past decade: a subset of women with PMDD show what's called a paradoxical response to allopregnanolone.7 Instead of allopregnanolone being calming, it appears to increase anxiety in these women.
The leading hypothesis is that GABA-A receptor subunit composition (specifically, the α2 and α4 subunits) varies between people. In women with the paradoxical response, allopregnanolone may activate receptor subtypes that produce anxiety rather than calm. The neurosteroid is the same. The receptors it lands on are different.
This is also why some women find that the entire luteal phase feels worse, not just the drop at the end. The high allopregnanolone phase itself can be the hard one.
Why "day 24" specifically
For a 28-day cycle, day 24 is roughly four days before the next period. That's where the late luteal allopregnanolone drop typically begins.
For longer cycles, the equivalent point shifts later. The luteal phase itself stays fairly fixed at 12 to 14 days, so the late luteal drop arrives 3 to 5 days before menstruation regardless of the cycle's total length. On a 35-day cycle, the equivalent of "day 24" is closer to day 31.
The "day 24" reference works as shorthand for the typical 28-day cycle. The point isn't the specific number. It's that the drop is consistent and timed relative to ovulation and menstruation, not relative to a calendar date.
Why the experience varies between women
The same biochemical event hits different brains differently. A few factors:
- GABA-A receptor subunit composition. Variable between people, partly genetic. Affects whether allopregnanolone is calming or activating.
- 5α-reductase and 3α-HSD activity. Some women convert progesterone to allopregnanolone faster or slower than others, affecting how much builds up and how quickly it clears.
- HPA axis tone. The body's stress response system. Higher baseline cortisol or more reactive cortisol response amplifies the late luteal vulnerability.
- Estrogen sensitivity. Variable receptor expression and binding affinity affect how much the estrogen drop adds to the experience.
- Sleep quality. Poor sleep amplifies neurotransmitter dysregulation across the cycle.
- History of mood disorders. Personal or family history of depression or anxiety increases the likelihood of severe luteal symptoms.
What the brain imaging shows
This isn't just inferred from hormone levels. Functional MRI studies have shown actual changes in brain activity across the cycle.
Amygdala reactivity (the brain region central to fear and emotional processing) is higher in the late luteal phase than the follicular phase.8 The amygdala is more responsive to negative stimuli when allopregnanolone is dropping.
Default mode network activity (a network associated with self-referential thought and rumination) also shifts across the cycle, with luteal-phase changes that align with mood symptoms in PMDD.9
Prefrontal control over emotional reactions weakens slightly in the late luteal in some women. So the brain becomes more reactive at the same time as the regulatory dampening from GABA gets quieter.
The point: the late luteal isn't a vague feeling. It's a measurable, visible change in how the brain is functioning.
What this means for tracking
Knowing the biochemistry doesn't make day 24 easier in real time. But it changes the interpretation of what you're experiencing.
Day 24 isn't a personal failure. It isn't a character flaw. It isn't a sign that something is wrong with your life. It's a measurable drop in a specific neurosteroid that acts on receptors involved in calm and anxiety regulation.
When you can name the mechanism, two things become easier:
- Recognizing the symptoms early in the drop, before they spiral
- Choosing what to do with them. Some of those things require a doctor. Many of them just require knowing it's chemistry, not personality.
Map your day 24.
My Body's BFF tracks mood, energy, sleep and cycle, and shows you when the patterns hit your body specifically. Free on iOS and Android.
Download the appThe takeaway
Progesterone makes allopregnanolone. Allopregnanolone tunes GABA receptors toward calm. GABA receptors downregulate during the elevated phase. Allopregnanolone drops sharply 3 to 5 days before menstruation. The downregulated receptors don't have the calming signal anymore, and the brain takes a few days to adjust.
That's what's happening on day 24.
It isn't moodiness. It isn't drama. It's a specific, identifiable neurochemical event happening at roughly the same point in every cycle. The science has names for all of it.